Oddo BHF lifts target for Sartorius Stedim stock to EUR 281.00

Published on 10/13/2026 at 14:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 22, 2026. Sartorius Stedim stock costs EUR 214.20 on October 13, 2026, up 0.66 percent versus the Euronext Paris close.

Array

Schwarz-Weiß-Reportage eines Technikers an einem Single-Use-Bioreaktor im Reinraum — Sartorius Stedim Biotech Techniker kontrolliert sorgfältig einen Single-Use-Bioreaktor im sterilen Reinraumlabor, ISIN FR0013154002, Illustration mit AI erstellt.

Oddo BHF raised its price target for Sartorius Stedim from EUR 239.00 to EUR 281.00 on October 2, 2026, while maintaining an Outperform rating, according to Ideal Investor. The new target is 31.19 percent above the EUR 214.20 Lang & Schwarz price used for this report. At 2:40 p.m. CEST on October 13, 2026, the stock was trading 0.66 percent above the Euronext Paris close of October 12, 2026 at EUR 212.80.

October 22 results carry estimates

Sartorius Stedim is scheduled to publish its quarter ended September 30, 2026 on October 22, 2026. Finanzen.ch reported on October 7, 2026 that three analysts expected revenue of EUR 755.60 million and earnings per share of EUR 1.19 for that quarter. The revenue estimate implies growth of 7.07 percent from EUR 705.70 million a year earlier.

Price remains below yearly high

The Euronext Paris quote showed a 52-week range of EUR 150.00 to EUR 225.00 on October 13, 2026, placing the Lang & Schwarz price 4.80 percent below the high. Trading volume was 16,471 shares at 2:25 p.m. CEST, versus an average volume of 90,590 shares, while the market capitalization stood at EUR 20.8 billion.

Valuation stays elevated

The P/E ratio was 70.66 on October 13, 2026, and the trailing dividend yield was 0.00 percent. Sartorius Stedim reported first-half 2026 revenue of EUR 1.53 billion and an underlying EBITDA margin of 31.40 percent, according to the company's investor-relations page. Its 2026 guidance calls for revenue growth of 6.00 percent to 10.00 percent in constant currencies and an underlying EBITDA margin slightly above 31.00 percent.

Comparison with peers

Sartorius Stedim (Euronext Paris, EUR): plus 0.66 percent, P/E 70.66, market capitalization EUR 20.8 billion
Danaher Corporation (NYSE, USD): plus 0.63 percent, P/E 39.29, market capitalization USD 155.5 billion
Thermo Fisher Scientific (NYSE, USD): plus 0.64 percent, P/E 35.62, market capitalization USD 244.9 billion

Target distance remains the key measure

At Lang & Schwarz, Sartorius Stedim was trading at EUR 214.20 on October 13, 2026 at 2:40 p.m. CEST, plus 0.66 percent versus the Euronext Paris close of October 12, 2026 at EUR 212.80. The EUR 281.00 Oddo BHF target leaves a quantified gap between the market price and the latest analyst assessment.

The further course of trading is shown by the continuously updated real-time quote of Sartorius Stedim stock.